AMES, Iowa, Nov. 1 /PRNewswire/ -- BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. , announced today a recent placement of the Nano eNabler(TM) system at the University of Rochester Medical Center in Rochester, New York. The University laboratory that is using the Nano eNabler system is projecting ground breaking technology surrounding smart bandage biomaterial engineering. The Nano eNabler system will aid University employees as they work toward developing bandages to detect cutaneous disease and direct scarless wound healing. The Nano eNabler system is a bench-top molecular printing system that dispenses tiny droplets of biological material onto a variety of surfaces with nanometer spatial precision. The placement at the University is part of a larger BioForce Nanosciences, Inc. pilot program to gather feedback on the performance of the Nano eNabler system, and facilitate real-world applications of the instrument. What is unique about the Nano eNabler system is it gives researchers a practical piece of equipment that serves as a bridge for nanotechnology in the biosciences.
The BioForce Nano eNabler molecular printer will be used by several people and groups in the laboratory at the University. One researcher is Christopher Striemer, Ph.D., chief technology officer with Pathologics, LLC. He says, "The BioForce eNabler system will allow us to explore the resolution limits of our protein array technology."
Another research group headed up by Professor Lewis Rothberg works with several different substrate materials, and many different immobilization chemistries. "The Nano eNabler system will allow us to do more than just print arrays on glass. This is going to be a huge boon to our reflective sensing research."
BioForce Product Manager Michael Lynch says, "The positive feedback BioForce is receiving from locations already enrolled in our pilot program is tremendous. This is a great opportunity for leading institutions to gain early access to a revolutionary surface patterning technology. There is a real need for the capabilities provided by the Nano eNabler system, and we are happy to see these early adopters embracing the technology." By the end of 2006, BioForce Nanosciences anticipates having shipped 20 systems-further evidence of the enthusiasm for wedding nanotechnology with the life sciences.
About BioForce Nanosciences, Inc.
BioForce Nanosciences is a nanotechnology tools and applications company, providing innovative and practical products that support the growth of the nanotechnology industry. BioForce has spent more than a decade on invention, research, and development of patented and patent-pending nanotechnology products. The core technology is the Nano eNabler(TM) bench-top molecular printer, a portal to new opportunities in nanotechnology. The Nano eNabler printing system opens the door to new and important applications in the biomedical and life sciences markets that lead to improved quality of life. BioForce continues to target inventions that further expand the reach of its proprietary technology and expand its robust patent, trademark, and IP portfolio.
BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) Company, brings inventions to the marketplace that complement existing innovations, licensing and acquisitions. BioForce is a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. . For more information, visit www.bioforcenano.com.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the Company's most recent filings with the Securities and Exchange Commission. The Company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.
BioForce Nanosciences, Inc.CONTACT: Deb Happe, Communication Coordinator of BioForce Nanosciences,Inc., +1-515-233-8333, Ext. 123, or dhappe@bioforcenano.com
Web site: http://www.bioforcenano.com//
